Cargando…

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma

The MET pathway plays a key role in various cancers, and its inhibition represents a potential treatment target. However, appropriate biomarkers are needed to facilitate the selection of patients who would benefit from MET inhibiting therapy. We herein conducted a robust confirmatory evaluation of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yoon Ah, Kim, Eun Kyung, Heo, Su Jin, Cho, Byoung Chul, Kim, Hye Ryun, Chung, Ji Myung, Yoon, Sun Och
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166528/ https://www.ncbi.nlm.nih.gov/pubmed/27994655 http://dx.doi.org/10.7150/jca.16686

Ejemplares similares

NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2019)

Author Correction: NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2020)

Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection
por: Cho, Yoon Ah, et al.
Publicado: (2019)

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
por: Kim, Hye Ryun, et al.
Publicado: (2016)

Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2020)

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
por: Lee, Ji Hyun, et al.
Publicado: (2021)

Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma
por: Chang, Hyun, et al.
Publicado: (2020)

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
por: Kang, Han Na, et al.
Publicado: (2020)

Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck
por: Choi, Seo Hee, et al.
Publicado: (2022)

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
por: Lim, Sun Min, et al.
Publicado: (2019)

Therapeutic Singing as a Swallowing Intervention in Head and Neck Cancer Patients With Dysphagia
por: Jo, Seongmoon, et al.
Publicado: (2021)

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
por: Yoo, Shin Hye, et al.
Publicado: (2019)

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
por: Huang, Kie Kyon, et al.
Publicado: (2016)

Mouse–human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
por: Kim, Hye Ryun, et al.
Publicado: (2020)

Predictive value of epigenetic alterations in head and neck squamous cell carcinoma
por: Koffler, Jennifer, et al.
Publicado: (2014)

Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk
por: Cho, Chang Gun, et al.
Publicado: (2006)

Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
por: Lim, Sun Min, et al.
Publicado: (2016)

Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas
por: Kim, Eun Kyung, et al.
Publicado: (2016)

XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample
por: Ji, Yong Bae, et al.
Publicado: (2010)

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2017)

Disproportional enrichment of FoxP3(+)CD4(+) regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma
por: Park, Seyeon, et al.
Publicado: (2022)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
por: Park, Seong Yong, et al.
Publicado: (2020)

Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
por: Kim, Min Hwan, et al.
Publicado: (2020)

Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
por: Kim, Min Hwan, et al.
Publicado: (2020)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Role of Met Axis in Head and Neck Cancer
por: Xu, Yiru, et al.
Publicado: (2013)

Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
por: Hong, Min Hee, et al.
Publicado: (2019)

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
por: Lee, Yun-Gyoo, et al.
Publicado: (2021)

Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2023)

EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas
por: Nelhűbel, Györgyi A., et al.
Publicado: (2021)

Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met Signaling
por: Rajamoorthi, Ananthi, et al.
Publicado: (2013)

Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis
por: Vsiansky, Vit, et al.
Publicado: (2018)

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2020)

Use of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Rare Head and Neck Cancers
por: Roh, Jong-Lyel, et al.
Publicado: (2008)

Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation
por: Ashman, J N E, et al.
Publicado: (2003)

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
por: Jiang, Chao, et al.
Publicado: (2022)

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2020)

Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction
por: Lee, Myungjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2jvh98g1pjupakalbhv2tf08q